Alvimopan reduces length of stay and costs in patients undergoing segmental colonic resections: Results from multicenter national administrative database

American Journal of Surgery

Volumn 208, Issue 6, 2014, Pages 919-925

  Simorov, Anton ^a   Thompson, Jon ^a   Oleynikov, Dmitry ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Alvimopan; Colon; Database; Outcomes; Resection; Sigmoidectomy

Indexed keywords

ALVIMOPAN; GASTROINTESTINAL AGENT; PIPERIDINE DERIVATIVE;

ADULT; AGED; COLON RESECTION; COMORBIDITY; CONFERENCE PAPER; CONVALESCENCE; DISEASE SEVERITY; DIVERTICULOSIS; FEMALE; HEALTH CARE COST; HOSPITAL COST; HOSPITAL READMISSION; HUMAN; ICD-9-CM; INTENSIVE CARE UNIT; INTESTINE FUNCTION; LAPAROSCOPIC SURGERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT RISK; PERIOPERATIVE PERIOD; SIGMOIDECTOMY; ADOLESCENT; ECONOMICS; INTENSIVE CARE; MIDDLE AGED; PROCEDURES; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UTILIZATION;

ADOLESCENT; ADULT; AGED; COLECTOMY; FEMALE; GASTROINTESTINAL AGENTS; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; PIPERIDINES; TREATMENT OUTCOME;

EID: 84916625544     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2014.08.011     Document Type: Conference Paper

References (25)

1. Healthcare Costs and Utilization Project (HCUP). 2002 National Statistics. Available at: http://www.ahrq.gov/HCUPnet. Accessed March 20, 2014.
2. S. Iyer, W.B. Saunders, and S. Stemkowski Economic burden of postoperative ileus associated with colectomy in the United States J Manag Care Pharm 15 2009 485 494
3. K.M. Augestad, and C.P. Delaney Postoperative ileus: impact of pharmacological treatment, laparoscopic surgery and enhanced recovery pathways World J Gastroenterol 16 2010 2067 2074
4. R.G. Baumgartner, N. Wells, and S.S. Chang Causes of increased hospital stay after radical cystectomy in a clinical pathway setting J Urol 167 2002 208 211
5. A. Kurz, and D.I. Sessler Opioid-induced bowel dysfunction: pathophysiology and potential new therapies Drugs 63 2003 649 671
6. A. Luckey, E. Livingston, and Y. Taché Mechanisms and treatment of postoperative ileus Arch Surg 138 2003 206 214
7. K. Holte, and H. Kehlet Postoperative ileus: progress towards effective management Drugs 62 2002 2603 2615
8. K. Holte, and H. Kehlet Postoperative ileus: a preventable event Br J Surg 87 2000 1480 1493
9. M.L. Austrup, and G. Korean Analgesic agents for the postoperative period. Opioids Surg Clin North Am 79 1999 253 273
10. C.P. Delaney, C. Craver, and M.M. Gibbons Evaluation of clinical outcomes with alvimopan in clinical practice: a national matched-cohort study in patients undergoing bowel resection Ann Surg 255 2012 731 738
11. C.T. Lee, S.S. Chang, and A.M. Kamat Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial Eur Urol 66 2014 265 272
12. D. Keller, and S.L. Stein Facilitating return of bowel function after colorectal surgery: alvimopan and gum chewing Clin Colon Rectal Surg 26 2013 186 190
13. C.P. Delaney, B.G. Wolff, and E.R. Viscusi Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies Ann Surg 245 2007 355 363
14. Available at: www.uhc.edu. Accessed March 20, 2014.
15. N.T. Nguyen, M. Hinojosa, and C. Fayad Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers J Am Coll Surg 205 2007 248 255
16. M.W. Hinojosa, Z.A. Murrell, and V.R. Konyalian Comparison of laparoscopic vs. open sigmoid colectomy for benign and malignant disease at academic medical centers J Gastrointest Surg 11 2007 1423 1429 discussion, 1429-0
17. A. Elixhauser, C. Steiner, and D.R. Harris Comorbidity measures for use with administrative data Med Care 36 1998 8 27
18. E.R. Viscusi, S. Goldstein, and T. Witkowski Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study Surg Endosc 20 2006 64 70
19. K. Ludwig, W.E. Enker, and C.P. Delaney Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway Arch Surg 143 2008 1098 1105
20. C.P. Delaney, J.L. Weese, N.H. Hyman Alvimopan Postoperative Ileus Study Group Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery Dis Colon Rectum 48 2005 1114 1125 discussion, 1125-6. Author reply 1127-1129
21. M.W. Büchler, C.M. Seiler, and J.R. Monson Clinical trial: alvimopan for the management of postoperative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study Aliment Pharmacol Ther 28 2008 312 325
22. B.G. Wolff, F. Michelassi, T.M. Gerkin Alvimopan Postoperative Ileus Study Group Alvimopan, a novel, peripherally acting μ opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus Ann Surg 240 2004 728 735
23. T.J. Bell, S.A. Poston, and M.D. Kraft Economic analysis of alvimopan in North American Phase III efficacy trials Am J Health Syst Pharm 66 2009 1362 1368
24. S.R. Kelley, B.G. Wolff, and J.K. Lovely Fast-track pathway for minimally invasive colorectal surgery with and without alvimopan (Entereg)™: which is more cost-effective? Am Surg 79 2013 630 633
25. W.M. Hilton, Y. Lotan, and D.J. Parekh Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis BJU Int 111 2013 1054 1060